Medtronic expands ICD (implantable cardioverter defibrillator) use to AF (atrial fibrillation) patients:
This article was originally published in Clinica
Medtronic has CE-marked for sale in Europe its Jewel AF implantable cardioverter defibrillator (ICD) for an expanded indication. The device, which is already available in Europe for treating patients who have atrial fibrillation (AF) combined with atrial tachycardia and ventricular tachycardia, can now be marketed for those with AF alone. Medtronic hopes to gain a similar expanded indication for the FDA-approved device in the US.